-
Novartis Partners with Ghana to Treat SCD, Offering Hydroxyurea and Opening Adakveo Trial
Novartis is working with Ghana to make hydroxyurea available to sickle cell patients in the African country, and to open a clinical trial of crizanlizumab. Click here to find out more.
What do you think of this partnership?
Sorry, there were no replies found.
Log in to reply.